| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |